Literature DB >> 1357984

Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments.

L Kapás1, L Hong, A B Cady, M R Opp, A E Postlethwaite, J M Seyer, J M Krueger.   

Abstract

Exogenously administered tumor necrosis factor-alpha (TNF-alpha) elicits several symptoms of generalized infections such as fever, increased sleep, and anorexia. The aim of the present work was to localize these effects of TNF-alpha to specific amino acid sequences of the parent molecule by characterizing the in vivo and in vitro activities of several synthetic TNF-alpha fragments. Intracerebroventricular injection of TNF-alpha elicited dose-dependent fevers and increases in non-rapid-eye-movement sleep (NREMS) in rabbits. Four fragments also promoted NREMS and five elicited monophasic fevers. All of the somnogenic fragments share the amino acid sequence 31-36. In rats, TNF-alpha and one of the fragments [TNF-alpha-(69-100)] suppressed 12-h food intake. Furthermore, TNF-alpha increased the expression of the intercellular adhesion molecule-1 and enhanced interferon-gamma-induced HLA-DR expression in human glioblastoma cell line. In contrast, none of the fragments possessed these in vitro activities. Our in vivo results support the concept that there are biologically active regions in the TNF-alpha molecule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357984     DOI: 10.1152/ajpregu.1992.263.3.R708

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  40 in total

1.  Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment.

Authors:  J Fang; Y Wang; J M Krueger
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Sleep and body temperature in TNFα knockout mice: The effects of sleep deprivation, β3-AR stimulation and exogenous TNFα.

Authors:  Éva Szentirmai; Levente Kapás
Journal:  Brain Behav Immun       Date:  2019-06-17       Impact factor: 7.217

3.  Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitination.

Authors:  Shuqin Zhan; Guo-Qiang Cai; Anni Zheng; Yuping Wang; Jianping Jia; Haotian Fang; Youfeng Yang; Meng Hu; Qiang Ding
Journal:  Biochim Biophys Acta       Date:  2010-11-18

4.  Sleep Apnea and its association with the Stress System, Inflammation, Insulin Resistance and Visceral Obesity.

Authors:  G Trakada; G Chrousos; S Pejovic; A Vgontzas
Journal:  Sleep Med Clin       Date:  2007-06

Review 5.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

6.  Peptidoglycan fragments decrease food intake and body weight gain in rats.

Authors:  K J Biberstine; R S Rosenthal
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities.

Authors:  Marina Tsaoussoglou; Edward O Bixler; Susan Calhoun; George P Chrousos; K Sauder; Alexandros N Vgontzas
Journal:  J Clin Endocrinol Metab       Date:  2009-11-19       Impact factor: 5.958

8.  Cytokine mRNA induction by interleukin-1beta or tumor necrosis factor alpha in vitro and in vivo.

Authors:  Ping Taishi; Lynn Churchill; Alok De; Ferenc Obal; James M Krueger
Journal:  Brain Res       Date:  2008-06-05       Impact factor: 3.252

9.  Effects of neurotoxic lesions in histaminergic neurons on brain tumor necrosis factor levels.

Authors:  X A Alvarez; A Franco; L Fernández-Novoa; R Cacabelos
Journal:  Agents Actions       Date:  1994-06

10.  Sleep fragmentation and sepsis differentially impact blood-brain barrier integrity and transport of tumor necrosis factor-α in aging.

Authors:  Mark R Opp; Amrita George; Kristyn M Ringgold; Kim M Hansen; Kristin M Bullock; William A Banks
Journal:  Brain Behav Immun       Date:  2015-07-26       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.